Technology
Health
Biotechnology

AzurRx BioPharma

$2.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.74%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AZRX and other stocks, options, ETFs, and crypto commission-free!

About

AzurRx BioPharma, Inc. Common Stock, also called AzurRx BioPharma, is a development stage company, which engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Read More It offers MS1819 and AZX1101 that are therapeutic proteins products under development. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY.

Employees
13
Headquarters
Brooklyn, New York
Founded
2014
Market Cap
38.96M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
73.62K
High Today
$2.30
Low Today
$2.20
Open Price
$2.30
Volume
28.10K
52 Week High
$3.75
52 Week Low
$1.00

Collections

Technology
Health
Biotechnology
Research And Development
2016 IPO
US
North America

Earnings

-$1.05
-$0.75
-$0.45
-$0.15
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.18 per share
Actual
Expected Mar 27, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.